CVI Holdings’s ANI Pharmaceuticals ANIP Stock Holding History

CVI Holdings’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-70,009	Closed	-$3.77M	–	232
2023 Q2	$3.77M	Buy	+70,009	New	+$3.1M	3.96%	8

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CVI Holdings's ANIP Position: Q3 2023 in Review

CVI Holdings sold out of ANI Pharmaceuticals (ANIP) in Q3 2023, closing a stake of 70,009 shares — an estimated $3.77M sold.

CVI Holdings first reported a position in ANIP in Q2 2023 and held it in 1 quarter. The position peaked at $3.77M in Q2 2023. 185 funds tracked by Wall St. Rank hold ANIP as of Q3 2023.

CVI Holdings reported no remaining ANI Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
CVI Holdings sold 70,009 ANI Pharmaceuticals shares in Q3 2023, an estimated $3.77M.
CVI Holdings first reported a position in ANI Pharmaceuticals in Q2 2023 and held it in 1 quarter.
CVI Holdings's ANI Pharmaceuticals position peaked at $3.77M in Q2 2023.
185 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2023.

Based on CVI Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.